Bellerophon Therapeutics Inc buy Slaandjivaa
Start price
12.04.17
/
50%
€16.13
Target price
12.10.17
€40.59
Performance (%)
38.42%
End price
12.10.17
€22.32
Summary
This prediction ended on 12.10.17 with a price of €22.32. The BUY prediction by Slaandjivaa for Bellerophon Therapeutics Inc saw massive gains of 38.42%. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bellerophon Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | -3.520% | -4.987% | 1.926% | 50.820% |
| iShares Nasdaq 100 | 0.261% | 1.102% | 15.434% | 90.843% |
| iShares Nikkei 225® | -4.953% | -3.352% | 29.010% | 51.211% |
| iShares S&P 500 | -0.823% | -0.042% | 10.814% | 62.945% |
Comments by Slaandjivaa for this prediction
In the thread Bellerophon Therapeutics Inc diskutieren
Slaandjivaa stimmt der Buy-Einschätzung von datca zu
Slaandjivaa stimmt am 12.04.2017 der Buy-Einschätzung von datca mit dem Kursziel 3$ zu.Überschrift: Bellerophon, erfolgreich tätig im Markt der Pulmonary Arterial Hypertension
(Laufzeit überschritten)